Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Investment Companies
Princess Private Equity (PEY) delivered a robust NAV TR increase in FY19 of 21.1% on the back of good earnings momentum and progress with the ‘buy and build’ strategy for key portfolio holdings. The company remains fully invested, with most of its €50m credit facility drawn at end-January 2020. It plans to repay this on receipt of proceeds from the Action exit, which was agreed in FY19. Looking ahead, PEY remains committed to its strategy of creating resilience in portfolio companies aimed at mitigating downside risks from a potential economic downturn.
Princess Private Equity Holding |
Actively driving portfolio resilience |
Investment trusts |
11 March 2020 |
Share price/discount performance
Three-year performance vs index
Gearing
Analyst
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Princess Private Equity (PEY) delivered a robust NAV TR increase in FY19 of 21.1% on the back of good earnings momentum and progress with the ‘buy and build’ strategy for key portfolio holdings. The company remains fully invested, with most of its €50m credit facility drawn at end-January 2020. It plans to repay this on receipt of proceeds from the Action exit, which was agreed in FY19. Looking ahead, PEY remains committed to its strategy of creating resilience in portfolio companies aimed at mitigating downside risks from a potential economic downturn.
|
PEY’s solid performance ahead of the European-listed PE universe |
|
|
Source: Princess Private Equity, Edison Investment Research |
The market opportunity
In the current late-cycle environment, PEY offers exposure to a private equity portfolio of high-conviction ideas, where it continues to focus on actively enhancing defensive attributes rather than simply buying defensive assets. It aims to achieve this through leveraging secular transformative tailwinds; pursuing a ‘buy and build’ strategy; driving operational improvement through its industry value creation (IVC) team; emphasising governance; and extending holding periods and underwriting a decline in market multiples. PEY’s higher weighting to less cyclical sectors vs the broader equity market may provide some downside protection if the coronavirus outbreak triggers an economic recession.
Why consider investing in Princess Private Equity?
■
Strong emphasis on portfolio defensiveness and resilience of cash flows.
■
Investment manager’s extensive experience (more than 20 years).
■
Well-resourced team and global platform.
■
Portfolio diversified across industries and vintages.
■
Attractive dividend policy with targeted pay-out of 5–8% of opening NAV.
Trading at narrower discount and attractive yield
PEY’s discount to NAV narrowed to c 5% at mid-February 2020 (vs a five-year average at 13.6%) following a strong share price appreciation, assisted by a significant NAV progression over the last 12 months. That said, the discount widened to 20.2% at end-February 2020 amid a negative broad market reaction to the coronavirus outbreak. The trust offers an attractive LTM dividend yield of 6.0%, well ahead of the peer average of 3.1%.
Exhibit 1: Company at a glance
Investment objective and fund background |
Recent developments |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Princess Private Equity Holding is an investment holding company domiciled in Guernsey that invests in private equity and private debt. Its portfolio may include direct, primary and secondary fund investments. Princess aims to provide shareholders with long-term capital growth as well as an attractive dividend yield. The shares are traded on the Main Market of the London Stock Exchange. |
■ 26 February 2020: January monthly report. NAV TR +0.2%. ■ 27 January 2020: December monthly report. NAV TR 5.7%, full-year 21.1%. ■ 23 December 2019: November monthly report. NAV TR 0.5%, ytd 14.5%. ■ 26 November 2019: October monthly report. NAV TR -0.4%, ytd 14.0%. ■ 20 November 2019: Q319 report. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Forthcoming |
Capital structure |
Fund details |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AGM |
May 2020 |
Ongoing charges |
1.8%* (LTM as at Q319) |
Group |
Partners Group |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interim results |
13 August 2020 |
Net gearing |
2.3% (end-September 2019) |
Manager |
Team-managed |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Year end |
31 December |
Annual mgmt fee |
1.5% |
Address |
Tudor House, PO Box 477, |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend paid |
June, December |
Performance fee |
See our previous note (p. 14) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Launch date |
1999 (listed since 2006) |
Company life |
Indefinite |
Phone |
+44 (0) 1481 730 946 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continuation vote |
None |
Loan facilities |
€50m |
Website |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividend policy and history (financial years) |
Share buyback policy and history (financial years) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PEY intends to pay a total annual dividend equivalent to c 5–8% of NAV per share, in two instalments. |
Under an authority granted in 2010, PEY’s directors may buy back up to 14.99% of shares or allot shares up to c 10% of the share capital, each year. However, no shares have been issued or repurchased since FY14. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholder base (at 2 March 2020) |
Portfolio exposure by asset type (at 31 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Top 10 holdings (at 31 January 2020) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Source: Princess Private Equity Holding, Edison Investment Research, Bloomberg. Note: *Including management fee and excluding incentive fee. **Not in top 10 holdings at end-January 2019.
Strong performance from PEY’s core strategy
PEY delivered a solid NAV TR of 21.1% in 2019 and the five-year NAV TR is 13.8% per year. Performance in 2019 was supported by significant portfolio valuation developments, which in total contributed 25.5pp to the NAV progression. In the period, NAV per share increased by €1.66 to €12.56, with the top 10 largest value drivers contributing €2.23 per share to this growth (Exhibit 2). This also accounts for the full-year dividend payment of €0.58 per share.
|
Exhibit 2: Top 10 NAV drivers in FY19 (€ per share) |
|
|
Source: Princess Private Equity Holding, Edison Investment Research. Note: As per number of shares at end-December 2018 (69.2m; unchanged during FY19). |
Write-ups were driven by continuous execution of the ‘buy and build’ strategy coupled with strong operational progress of several companies, including Permotio International, GlobalLogic, KinderCare Education and Foncia. Other portfolio holdings also saw solid earnings momentum, including PCI Pharma Services, Vishal Mega Mart and Techem Metering. The most notable exit agreed in the period was Action, PEY’s second largest portfolio holding at end-December 2019 (c 11% of its NAV). The fund has also fully exited Vermaat and Agiliti, while making a partial exit from Global Blue and Ceridian HCM (more details can be found below).
Solid NAV progression in FY19 triggered a 37.4% share price return, with the discount narrowing to 13.2% from 22.9% during the year. In January 2020, NAV increased by a slight 0.2% and the discount narrowed further to 11%. On 10 March 2020, PEY traded at a 23.3% discount to NAV after its share price declined 13.8% since end-January 2020. We believe this is related to the broad market uncertainty amid the coronavirus outbreak, as illustrated by the 14.8% drop in the MSCI World Index since end-January 2020.
Remaining fully invested despite several exits
Investments in FY19 totalled €69.3m and included two consumer care companies (Blue River PetCare and Schleich), two healthcare holdings (Confluent Health and Nestle Skin Health -rebranded to Galderma) as well as one company from each of the IT, financial and industrial sectors (Idera, Project Fox, and BCR Group, respectively). The company has also invested in Convex Group, an international speciality insurer and reinsurer. Moreover, PEY made an €8.0m follow-on investment in Permotio to support the company's ongoing 'buy and build' strategy. For more details on the above transactions, please see our previous review note.
PEY’s investments since we last published include an €0.7m add-on-investment in SHL, a global psychometric testing provider, in November 2019, as well as €9.2m invested in Axel Springer as part of a voluntary tender offer in December 2019, along with KKR and other investors. The company is a Germany-based publishing house, which offers a portfolio of online classified portals as well as print and digital content in over 40 countries.
Post FY19, PEY acquired a stake in Eye Care Partners (ECP) for €10.1m. The company provides medical vision services across 13 states in the US. It has medical optometry and ophthalmology practices in more than 450 locations and employs 500 optometrists, 85 ophthalmologists and over 4.4k clinic staff. Partners Group will become ECP’s majority shareholder and will work with the company’s management on its organic and M&A growth. ECP will increase PEY’s exposure to the healthcare sector and North America, which represented 14% and 32% of its NAV at end-December 2019, respectively. Partners Group expects to close the transaction in Q120.
PEY was quite active on the investment front at the start of the year, investing €27.9m in January 2020. This includes an €11.2m investment in eResearch Technology, a provider of integrated online software application services for pharmaceutical, biotechnology and medical device industries. PEY also advanced €9.9m to Allied Universal, a US-based provider of facility and security services. Finally, the trust made a €6.8m follow-on investment in AMMEGA, a belt technology company, which will use the funds to finance the acquisition of Midwest Industrial Rubber, a US-based provider of facility and security services.
|
Exhibit 3: Investments, realisations and net liquidity* since 2015 until end-January 2020 |
|
|
Source: Princess Private Equity Holding, Edison Investment Research. Note: *Net liquidity calculated as liquid resources to NAV. |
Realisations in FY19 were €104.1m. Of this amount c 39% was related to PEY’s third-party fund portfolio, which represented c 7% of PEY’s NAV at end-December 2019 (vs 13% at end-December 2018). The largest equity realisation was the full exit of Vermaat, a Dutch market leader in premium outsourced catering and hospitality services. This transaction generated €18.0m proceeds, representing a return of 2.75x cost over a holding period of around four years, which translated into a gross IRR of more than 30%. Since PEY entered Vermaat in 2015, the company increased its EBITDA by 1.7x, assisted by expansion of its locations to 360 from 188, five add-on acquisitions and market entry into Germany. Moreover, PEY’s exit from Agiliti at a multiple of 2.63x (since investment in 2007) generated proceeds of €10.8m. The company also received €8.0m from the ongoing sale of its shares in Ceridian HCM, a global provider of human resources software and services, following its listing on the New York Stock Exchange in April 2018.
Post period-end realisations include €97.7m proceeds from the full exit from Action. PEY states the transaction represented a solid multiple of 35.7x since the investment in 2011. The company has also agreed a partial exit from Global Blue, a tourism shopping tax refund company headquartered in Nyon (Switzerland), following its merger with Far Point Acquisition Corporation. This transaction valued Global Blue at €2.3bn, representing a modest uplift to the carrying value as at 31 December 2019. PEY anticipates it will receive €8.0m proceeds on completion of the transaction, which is expected in Q220. In January 2020, PEY received €10.2m realisations, mostly from its legacy fund portfolio, which further reduced its share in NAV to 6% at end-January 2020.
High exposure to focus sectors
At end-January 2020, the 10 largest portfolio holdings represented 54.2% of NAV versus 42.0% a year earlier. This results from significant valuation uplifts of the largest holdings throughout the year, in particular Permotio and Action, which has also led to an increase in the share of consumer discretionary sector in the portfolio (35% at end-January 2020 vs 30% at end-December 2018). We note, however, that this will change following the completion of the Action exit. Investments from Partners Group/co-lead increased to 71% of NAV at end-December 2019 from 62% at end-December 2018 at the expense of legacy third-party funds, which represented 7% of NAV at end-December 2019 and decreased to 6% at end-January 2020 (Exhibit 4).
|
Exhibit 4: Investments by asset type |
Exhibit 5: Investments by industries |
|
|
|
Source: Princess Private Equity Holding, Edison Investment Research. Note: Data at 31 December 2019 (last available). |
Source: Princess Private Equity Holding, Edison Investment Research. Note: Data at 31 January 2020. |
|
Exhibit 4: Investments by asset type |
|
|
Source: Princess Private Equity Holding, Edison Investment Research. Note: Data at 31 December 2019 (last available). |
|
Exhibit 5: Investments by industries |
|
|
Source: Princess Private Equity Holding, Edison Investment Research. Note: Data at 31 January 2020. |
Despite the broader economy slowdown recently, portfolio companies delivered solid growth in sales and EBITDA in the 12 months ending December 2019 (Exhibit 6).
Exhibit 6: Sample* valuation and performance metrics for direct portfolio
End-December 2019 |
End-September 2019 |
End-December 2018 |
US buyout average** |
|
Valuation metrics |
||||
EV/EBITDA |
14.0x |
14.2x |
13.0x |
11.9x |
Net debt/EBITDA |
5.1x |
5.1x |
5.4x |
6.6x |
Weighted average leverage |
38.6%*** |
38.3%*** |
43.2%*** |
|
Weighted average EV |
€2.5bn |
€3.1bn |
€2.5bn |
|
Performance metrics (12m) |
||||
Weighted average revenue growth |
9.6% |
11.7% |
10.2% |
|
Weighted average EBITDA growth |
12.4% |
14.1% |
11.5% |
|
Weighted average revenue |
€0.8bn |
€1.3bn |
€1.1bn |
Source: Princess Private Equity Holding, Edison Investment Research. Note: *Valuation metrics are based on a sample of all direct equity investments, which constituted 77.9% of NAV at end-December 2019, 84.3% of NAV at end-September 2019 and 73.9% at end-December 2018. Performance metrics are based on sample of all companies where comparable data are available and not driven mainly by M&A (57.7% of NAV at end-December 2019, 69.1% of NAV at end-September 2019 and 55.8% at end-December 2018). **2019 average US buyout multiples according to McKinsey A new decade for private markets report. ***Defined as debt as a % of enterprise value.
Outlook: Creating instead of buying defensiveness
The investment manager remains wary of the current late-cycle environment with increasing downside risks from low growth and geopolitical uncertainties. It intends to mitigate these through proactively facilitating growth, creating resilience/defensiveness and building out cash flows in its portfolio companies rather than simply buying defensive assets, which currently exhibit demanding valuations/limited yields and in some instances vulnerability to disruption (eg, some large-cap consumer companies). This shall be achieved through:
■
Leveraging secular transformative tailwinds in a five- to 10-year horizon, such as digitalisation, aging of society/health awareness, automation, sustainability etc., supporting organic growth.
■
Displaying a preference for highly fragmented sectors allowing pursuit of a ‘buy and build’ strategy.
■
Implementing operational improvement (leading, among others, to margin enhancement) by the investment manager’s IVC team.
■
Placing emphasis on governance and designing an optimal board of directors in the companies it invests in.
■
Extending holding periods and running winners for longer
■
Conservative underwriting which assumes a decline in market multiples during the holding period.
PEY will continue focusing on ‘thematic sourcing’, namely high-conviction ideas within selected subsectors of consumer, healthcare, industrials, financial and business services and TMT industries. It targets the global middle and upper-middle buyout market where pricing is somewhat less demanding in comparison to large and megadeals. Moreover, it will shy away from highly competitive bidding processes and look to pre-empt a sales process and leverage its industry expert network to find opportunities ahead of other potential investors.
Although PEY is looking for attractive new investments, we note it is currently fully invested and had a net negative liquidity at €73.2m (8.4% of NAV) at end-January 2020 (vs a positive €6.1m at end-January 2019), with €48.5m of its €50m credit line drawn to fund new investments and the December dividend pay-out. In FY19, PEY’s unfunded commitments decreased by €14.1m to €79.6m at end-December 2019, largely due to a reduction in commitments to legacy funds (down €11.2m). After adding PEY-calculated net gearing and subtracting the undrawn part of its credit facility from total unfunded commitments, we arrive at an overcommitment ratio (as a percentage of NAV) of c 17.4% at end-January 2020 (vs 10.0% at end-October 2019 and 7.8% at end-January 2019).
However, PEY intends to pay down the credit facility with the proceeds from Action following the closure of the transaction in May 2020. PEY should receive a total of €97.7m, of which €88.6m will be paid on closure of the deal (the remaining €9.1m will be due in May 2023). We estimate that, when adjusted for the €88.6m proceeds, pro forma net liquidity and PEY’s overcommitment ratio at end-January 2020 would be a positive €15.4m (1.8% of NAV) and c 7%, respectively. Moreover, we note the balance of unfunded commitments is somewhat overstated as legacy funds represented c 34% of these at end-December 2019 (vs 41% at end-December 2018) but they are out of their investment period and are unlikely to be called in full.
Peer group comparison
In Exhibit 7, we show a group of the larger funds in the Association of Investment Companies’ private equity sector, of which PEY is a member, all in sterling terms. The peers are geographically diverse and follow a variety of investment strategies, from wholly or largely funds-of-funds to wholly or largely direct, and may also include secondary investments, co-investments and private debt.
After a strong NAV progression in the 12 months ended January 2020, PEY’s NAV total return performance is above the peer group average. The trust also slightly outperformed the peer group average for NAV total returns over three and five years (in sterling terms). Share price return was also solid compared to its peers, particularly over the 12 months ending January 2020. PEY’s discount to NAV has widened to 23.3% from 11% at end-January 2020, following the broad market sell-off in late February 2020 amid the coronavirus outbreak. However, PEY’s discount is still in line with the average for its peers, which also suffered significant share price depreciation in this period. PEY’s dividend yield at 6.0% is the second highest among its peers and well ahead of the 3.1% average.
Exhibit 7: Listed private equity investment companies peer group, at 10 March 2020*
% unless stated |
Country focus |
Market cap (£m) |
NAV TR 1 year |
NAV TR 3 years |
NAV TR 5 years |
Price TR 1 year |
Price TR 3 years |
Price TR 5 years |
P/NAV premium/ |
Dividend yield (%) |
Princess Private Equity |
Global |
552.8 |
16.0 |
39.6 |
108.2 |
23.6 |
40.7 |
140.0 |
(23.3) |
6.0 |
Apax Global Alpha |
Global |
761.2 |
16.1 |
34.5 |
N/A |
9.4 |
18.5 |
N/A |
(15.4) |
6.2 |
BMO Private Equity Trust |
Global |
260.3 |
5.1 |
25.1 |
70.9 |
5.5 |
33.3 |
95.7 |
(9.0) |
4.1 |
Deutsche Beteiligungs |
Europe |
384.1 |
8.5 |
37.4 |
97.6 |
11.4 |
37.7 |
99.5 |
(0.2) |
5.0 |
HarbourVest Global Priv Equity |
Global |
1,285.8 |
14.7 |
38.8 |
97.6 |
28.8 |
53.6 |
117.3 |
(21.0) |
0.0 |
HgCapital Trust |
UK |
955.4 |
24.1 |
71.4 |
140.7 |
22.2 |
65.7 |
152.8 |
(7.0) |
2.0 |
ICG Enterprise Trust |
UK |
589.6 |
10.1 |
41.1 |
88.0 |
7.3 |
36.5 |
76.2 |
(24.6) |
2.6 |
JPEL Private Equity |
Global |
184.6 |
(4.5) |
10.4 |
64.5 |
(7.7) |
(1.4) |
73.7 |
(28.8) |
0.0 |
Oakley Capital Investments |
Europe |
467.7 |
24.5 |
55.9 |
82.9 |
28.8 |
61.6 |
57.1 |
(31.7) |
1.9 |
Pantheon International |
Global |
1,171.0 |
9.2 |
32.4 |
82.9 |
3.3 |
26.7 |
65.5 |
(21.8) |
0.0 |
Standard Life Private Eq |
Europe |
499.7 |
7.2 |
36.4 |
95.9 |
22.0 |
47.8 |
122.1 |
(24.6) |
3.9 |
Symphony International Hldg |
APAC |
186.1 |
11.2 |
2.2 |
22.5 |
(20.6) |
(25.4) |
18.2 |
(52.1) |
5.3 |
Peer group average |
608.2 |
12.2 |
35.4 |
86.5 |
11.2 |
32.9 |
92.6 |
(21.6) |
3.1 |
|
PEY rank in group (11 funds) |
6 |
4 |
4 |
2 |
3 |
5 |
2 |
7 |
2 |
Source: Morningstar, Edison Investment Research. Note: *Performance data to 31 January 2020. TR: total return. All returns expressed in sterling terms.
|
|
Research: Healthcare
In February 2020, NeuroVive announced a rights issue (subject to EGM approval) aiming to raise up to SEK74m gross at a price of SEK0.80 per share, of which 90% (SEK67m) is guaranteed. According to its updated strategy, the main focus will be on KL1333 and NV354 for primary mitochondrial diseases (PMDs), NeuroViveâs area of expertise. Our model suggests this would cover operating costs for 2020 and into 2021. The most significant share price catalyst in the near term is KL1333 Phase Ia/b results, due in H220. Our updated valuation is SEK1.72bn or SEK6.4 per share, which includes the guaranteed amount of the rights issue.